The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.

On Friday, July 18, the Federal Circuit issued a precedential decision reversing the Central District of California’s denial ...

A court sided with Medtronic (NYSE:MDT), overturning a 2023 verdict ordering the medtech giant to pay a significant amount in ...

In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart ...